[Prophylactic treatments of opportunistic infections in acquired immunodeficiency syndrome].
Longuet
P
P
Service des Maladies Infectieuses et Tropicales, Hôpital Bichat-Claude Bernard, Paris.
Leport
C
C
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000628:therapy*; D004359:Drug Therapy, Combination; D017245:Foscarnet; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009894:Opportunistic Infections / Q000150:complications / Q000517:prevention & control*; D010419:Pentamidine / Q000627:therapeutic use; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000517:prevention & control*; D013411:Sulfadiazine / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D013411:Sulfadiazine; D017245:Foscarnet; D010419:Pentamidine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D010746:Phosphonoacetic Acid; D015774:Ganciclovir
Traitements prophylactiques des infections opportunistes au cours du syndrome d'immunodépression acquise.